Nobuaki Matsubara

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Metastatic Renal Cell Carcinoma

Top Venues

Cancer medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Japanese journal of clinical oncology

International journal of urology : official journal of the Japanese Urological Association

This page only lists publications with an associated author ORCID identifier.

Publications

Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, Shiro Hinotsu, Satoru Takahashi, Tsutomu Takeuchi, Kazuhiro Suzuki, Hiroshi Shinmoto, Tsutomu Tamada, Takahiro Inoue, Mikio Sugimoto, Atsushi Takenaka, Tomonori Habuchi, Hitoshi Ishikawa, Takashi Mizowaki, Shiro Saito, Hideaki Miyake, Nobuaki Matsubara, Norio Nonomura, Hideki Sakai, Akihiro Ito, Osamu Ukimura, Hideyasu Matsuyama, Isao Hara
Japanese clinical practice guidelines for prostate cancer 2023. International journal of urology : official journal of the Japanese Urological Association (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A phase 1 study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Yasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, Yoichi Naito, Shunsuke Kondo, Kenichi Harano, Kan Yonemori, Kiyotaka Yoh, Yuan Gu, Tetsuya Mita, Xuejun Chen, Eiji Ueda, Noboru Yamamoto, Toshihiko Doi, Toshio Shimizu
PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study. Cancer medicine 13 (8) (2024)
Yasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, Yoichi Naito, Shunsuke Kondo, Kenichi Harano, Kan Yonemori, Kiyotaka Yoh, Yuan Gu, Tetsuya Mita, Xuejun Chen, Eiji Ueda, Noboru Yamamoto, Toshihiko Doi, Toshio Shimizu
PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study. Cancer medicine 13 (8) (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Yasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, Yoichi Naito, Shunsuke Kondo, Kenichi Harano, Kan Yonemori, Kiyotaka Yoh, Yuan Gu, Tetsuya Mita, Xuejun Chen, Eiji Ueda, Noboru Yamamoto, Toshihiko Doi, Toshio Shimizu
PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study. Cancer medicine 13 (8) (2024)
William Kevin Kelly, Daniel Costin Danila, Chia-Chi Lin, Jae Lyun Lee, Nobuaki Matsubara, Patrick J Ward, Andrew J Armstrong, David W Pook, Miso Kim, Tanya Barauskas Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M Smith, Jamie N Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J Appleman
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer discovery (2023)
Kaede Baba, Megumi Kawamoto, Kanako Mamishin, Mao Uematsu, Hikari Kiyohara, Akira Hirota, Nobuyuki Takahashi, Misao Fukuda, Shota Kusuhara, Hiromichi Nakajima, Chikako Funasaka, Takehiro Nakao, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara
The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer. Cancer medicine (2023)
Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, Ryuji Matsumoto, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane
TAS0313 Plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma. Molecular cancer therapeutics (2023)
Archana M Agarwal, Fred Saad, Arun A Azad, Joaquin Mateo, Nobuaki Matsubara, Neal D Shore, Jayeta Chakrabarti, Hsiang-Chun Chen, Silvana Lanzalone, Alexander Niyazov, Karim Fizazi
TALAPRO-3 clinical trial protocol: phase III study of talazoparib plus enzalutamide in metastatic castration-sensitive prostate cancer. Future oncology (London, England) (2023)
Nobuaki Matsubara, Hideyasu Matsuyama, Hirotaka Kazama, Takeshi Seto, Yoshinori Sunaga, Kazuhiro Suzuki
Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance. Japanese journal of clinical oncology (2023)
Nobuaki Matsubara, Shota Kusuhara, Noboru Yamamoto, Kazuki Sudo, Masahiko Yanagita, Kosho Murayama, Hisashi Kawasumi, Deanna L Russell, Da Yin, Toshio Shimizu
Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study. Cancer chemotherapy and pharmacology (2023)
Kojiro Ohba, Keisuke Monji, Takahiro Osawa, Kazutoshi Yamana, Yosuke Yasuda, Hajime Tanaka, Yuki Nakagawa, Tamaki Fukuyama, Nobuaki Matsubara, Hirotsugu Uemura, Hideki Sakai, Masatoshi Eto
Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study. International journal of urology : official journal of the Japanese Urological Association (2023)
Nobuaki Matsubara, Junji Yonese, Takahiro Kojima, Haruhito Azuma, Hiroaki Matsumoto, Thomas Powles, Jonathan E Rosenberg, Daniel P Petrylak, Maria Matsangou, Chunzhang Wu, Mary Campbell, Mayumi Yamashiro
Japanese subgroup analysis of EV-301: An open-label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma. Cancer medicine (2022)
Toshihiko Doi, Kohei Shitara, Takashi Kojima, Yasutoshi Kuboki, Nobuaki Matsubara, Hideaki Bando, Kiyotaka Yoh, Yoichi Naito, Hiroshi Hirai, Yukinori Kurokawa, Terufumi Kato, Chigusa Morizane
Phase I study of the irreversible fibroblast growth factor receptor 1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors. Cancer science (2022)
Chikako Funasaka, Yoichi Naito, Shota Kusuhara, Takehiro Nakao, Hiromichi Nakajima, Megumi Kawamoto, Kaede Baba, Kanako Mamishin, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Ako Hosono, Tomoaki Sasaki, Toshikatsu Kawasaki, Toru Mukohara
Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study. Japanese journal of clinical oncology (2022)
Takeshi Kuroe, Reiko Watanabe, Ryo Morisue, Saori Miyazaki, Motohiro Kojima, Shawhay Charles Murata, Tokiko Nakai, Tetsuro Taki, Shingo Sakashita, Naoya Sakamoto, Nobuaki Matsubara, Hitoshi Masuda, Tetsuo Ushiku, Genichiro Ishii
Dirty necrosis in renal cell carcinoma is associated with NETosis and systemic inflammation. Cancer medicine (2022)
Nobuaki Matsubara, Kazuo Nishimura, Satoru Kawakami, Jae Young Joung, Hiroji Uemura, Takayuki Goto, Tae Gyun Kwon, Mikio Sugimoto, Masashi Kato, Shian-Shiang Wang, See-Tong Pang, Chung-Hsin Chen, Tomoko Fujita, Masahiro Nii, Liji Shen, Melanie Dujka, Maha Hussain, Johann de Bono
Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis. Japanese journal of clinical oncology 52 (5) (2022)
Nobuaki Matsubara, Johann S de Bono, David Olmos, Giuseppe Procopio, Satoru Kawakami, Yuksel Urun, Robbert van Alphen, Aude Flechon, Michael A Carducci, Young Deuk Choi, Sebastien J Hotte, Ernesto Korbenfeld, Gero Kramer, Archana M Agarwal, Kim N Chi, Simon Dearden, Christopher Gresty, Jinyu Kang, Christian Poehlein, Elizabeth A Harrington, Maha H A Hussain
Olaparib Efficacy in Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1, BRCA2 or ATM Alterations Identified by Testing Circulating Tumor DNA. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Yoichi Naito, Yasutoshi Kuboki, Masafumi Ikeda, Kenichi Harano, Nobuaki Matsubara, Shigeyuki Toyoizumi, Yuko Mori, Natsuki Hori, Takashi Nagasawa, Takahiro Kogawa
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study. Investigational new drugs 39 (6) (2021)